As Americans become more concerned about quality issues with prescription medications made abroad, one company is trying to offer an additional layer of reassurance — by doing chemical analysis before dispensing drugs to patients.

Valisure launched just over a year ago, positioning itself as a pharmacy, a lab, and a wholesaler. Now licensed in 38 states and with a staff of 25 in Yale University’s Science Park in New Haven, Connecticut, Valisure analyzes some 2,000 drug products — mostly generics, but also some brands — to introduce an additional level of quality control into the system.

“We thought, wouldn’t it be great to have chemical analysis at the end of the supply chain, here in the U.S. where it matters the most, when patients are going to get the drug,” Valisure Founder and CEO David Light told MedPage Today in an interview.

To read the rest of the article by Kristina Fiore, please click here.